118. 脊髄髄膜瘤 Myelomeningocele Clinical trials / Disease details

臨床試験数 : 5 / 薬物数 : 7 - (DrugBank : 4) / 標的遺伝子数 : 2 - 標的パスウェイ数 : 10

diseases per page:

Showing 1 to 5 of 5 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04652908 (ClinicalTrials.gov)	June 21, 2021	25/11/2020	Cellular Therapy for In Utero Repair of Myelomeningocele - The CuRe Trial	Phase 1/2a Trial of Placental Mesenchymal Stem Cells for Repair of Fetal Myelomeningocele	Myelomeningocele	Biological: Placental Mesenchymal Stem Cells seeded on a commercially available dural graft extracell ...	Diana Lee Farmer	California Institute for Regenerative Medicine (CIRM)	Recruiting	19 Weeks	25 Weeks	All	55	Phase 1/Phase 2	United States
2	NCT04738539 (ClinicalTrials.gov)	March 2, 2021	1/2/2021	Efficacy of Contrast Enhanced Voiding Urosonography for Urodynamic Studies	Efficacy of Contrast Enhanced Voiding Urosonography for Urodynamic Studies	Myelomeningocele;Neurogenic Bladder;Tethered Cord Syndrome;Bladder, Neurogenic;Urologic Diseases;Neu ...	Drug: Contrast Enhanced Voiding Urosonography with Urodynamic Testing;Diagnostic Test: Urodynamic Te ...	University of Virginia	NULL	Recruiting	N/A	18 Years	All	105		United States
3	JPRN-UMIN000040088	2019/07/01	07/04/2020	Safety Assessment Clinical Test of Fetal Surgery for Myelomeningocele	Safety Assessment Clinical Test of Fetal Surgery for Myelomeningocele- Safety Assessment Clinical Te ...	Myelomeningocele	MMC(Myelomeningocele) open fetal surgery	OSAKA UniversityDepartment of MedicineDivision of Obstetrics and Gynecology	NULL	Recruiting	20years-old	Not applicable	Female	15	Not selected	Japan
4	NCT04468568 (ClinicalTrials.gov)	October 1, 2017	1/3/2020	In Utero Repair of Myelomeningocele: Atosiban Versus Terbutaline	Assessment of Maternal Blood Gas Changes When Using Atosiban and Terbutaline as Tocolytic Agents, Du ...	Myelomeningocele;Terbutaline Adverse Reaction;Pregnancy; Malformation Central Nervous System	Drug: Atosiban;Drug: Terbutaline	University of Sao Paulo General Hospital	NULL	Completed	18 Years	40 Years	Female	25		Brazil
5	NCT00175123 (ClinicalTrials.gov)	May 2005	9/9/2005	Effect of Botulinum Toxin in Neurogenic Bladders in Children With Myelomeningocele	Phase 4 Study of the Effect of Botulinum-A Toxin Injected in Neurogenic Overactive Bladders of Child ...	Myelomeningocele;Bladder, Neurogenic	Drug: Botulinum A toxin	University of Aarhus	Aarhus University Hospital	Active, not recruiting	2 Years	16 Years	Both	30	Phase 4	Denmark

First Previous1Next Last